Cargando…

Type 2 inflammation and biological therapies in asthma: Targeted medicine taking flight

The field of asthma has undergone a dramatic change in recent years. Advances in our understanding of type 2 airway inflammation have driven the discovery of monoclonal antibodies targeting specific aspects of the immune pathway. In landmark trials, these drugs have shown efficacy in reducing asthma...

Descripción completa

Detalles Bibliográficos
Autores principales:	Howell, Imran, Howell, Aleksandra, Pavord, Ian D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Rockefeller University Press 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10239209/ https://www.ncbi.nlm.nih.gov/pubmed/37265457 http://dx.doi.org/10.1084/jem.20221212

Ejemplares similares

Recovery of Breakthrough Asthma Attacks Treated With Oral Steroids While on Monoclonal Antibody Therapy: Protocol for a Prospective Observational Study (BOOST)
por: Howell, Imran, et al.
Publicado: (2023)

Precision medicine in pediatric severe asthma: Targeted blockade of type 2 inflammation
por: Larkin, Allyson S., et al.
Publicado: (2022)

Severe T2-high asthma in the biologics era: European experts' opinion
por: Pavord, Ian, et al.
Publicado: (2019)

Editorial: Metal Biology Takes Flight: The Study of Metal Homeostasis and Detoxification in Insects
por: Mohr, Stephanie E., et al.
Publicado: (2018)

Biological Treatments and Target Therapies for Pediatric Respiratory Medicine: Not Only Asthma
por: Ghirardo, Sergio, et al.
Publicado: (2022)

The discovery of novel neuropeptides takes flight
por: Nichols, Ruthann
Publicado: (2002)

Gene editing in birds takes flight
por: Woodcock, Mark E., et al.
Publicado: (2017)

Predicting the benefits of type-2 targeted anti-inflammatory treatment with the prototype Oxford Asthma Attack Risk Scale (ORACLE)
por: Couillard, Simon, et al.
Publicado: (2021)

Biological therapies targeting the type 2 inflammatory pathway in severe asthma (Review)
por: Fildan, Ariadna Petronela, et al.
Publicado: (2021)

Step 4: stick or twist? A review of asthma therapy
por: Slater, Mariel G, et al.
Publicado: (2016)

Monitoring asthma in childhood: lung function, bronchial responsiveness and inflammation
por: Moeller, Alexander, et al.
Publicado: (2015)

ICARUS takes flight beneath the Gran Sasso
Publicado: (2011)

Novel coronavirus takes flight from bats?
por: York, Ashley
Publicado: (2020)

Asthma in pregnancy: An update
por: Couillard, Simon, et al.
Publicado: (2020)

Salmeterol plus fluticasone propionate versus fluticasone propionate plus montelukast: a randomised controlled trial investigating the effects on airway inflammation in asthma
por: Pavord, Ian, et al.
Publicado: (2007)

PATIENTS WITH ASTHMA OR ATOPIC DERMATITIS TAKING BIOLOGIC THERAPIES HAVE REDUCED SARS-COV-2 VACCINE RESPONSE AT SIX MONTHS
por: RUNNSTROM, MARTIN C, et al.
Publicado: (2022)

Molecular Targets for Biological Therapies of Severe Asthma
por: Pelaia, Corrado, et al.
Publicado: (2020)

Commentary on Eosinophilic Inflammation, Coronavirus Disease 2019, and Asthma: Are inhaled corticosteroids the missing link?
por: Ho, Kam Sing, et al.
Publicado: (2021)

The effects of the COVID-19 lockdown on severe asthma in patients taking biologic therapy and air pollution in Riyadh
por: Ayaz, Khan Mohammad, et al.
Publicado: (2021)

Capturing Biology in Flight
por: Robinson, Carol V.
Publicado: (2018)

COVID-19, severe asthma and biologicals targeting type 2 inflammation: results in a third-level hospital in Madrid, Spain.
por: Estirado, Alicia Domínguez, et al.
Publicado: (2021)

Can I take a space flight? Considerations for doctors
por: Grenon, S Marlene, et al.
Publicado: (2012)

Personalized medicine with biologics for severe type 2 asthma: current status and future prospects
por: Godar, Marie, et al.
Publicado: (2017)

TGF-β Isoform Specific Regulation of Airway Inflammation and Remodelling in a Murine Model of Asthma
por: Bottoms, Stephen E., et al.
Publicado: (2010)

Dose-response relationship of ICS/fast-onset LABA as reliever therapy in asthma
por: Beasley, Richard, et al.
Publicado: (2019)

Patent Medicines in Drug Stores
por: Howell,
Publicado: (1879)

Eligibility of C-BIOPRED severe asthma cohort for type-2 biologic therapies
por: Deng, Zhenan, et al.
Publicado: (2023)

Personalized and Precision Medicine in Asthma and Eosinophilic Esophagitis: The Role of T2 Target Therapy
por: Bagnasco, Diego, et al.
Publicado: (2023)

Dupilumab is effective in type 2‐high asthma patients receiving high‐dose inhaled corticosteroids at baseline
por: Bourdin, Arnaud, et al.
Publicado: (2020)

Selection of Biologics for Type 2–High Asthma
por: Yilmaz, Insu
Publicado: (2019)

Fractional exhaled nitric oxide (FeNO): the future of asthma care?
por: Wang, Kay, et al.
Publicado: (2023)

Asthma remission: what is it and how can it be achieved?
por: Thomas, Dennis, et al.
Publicado: (2022)

The impact of poor asthma control among asthma patients treated with inhaled corticosteroids plus long-acting β(2)-agonists in the United Kingdom: a cross-sectional analysis
por: Pavord, Ian D., et al.
Publicado: (2017)

Type 2 inflammation in asthma and other airway diseases
por: Maspero, Jorge, et al.
Publicado: (2022)

Pathobiology of Type 2 Inflammation in Asthma and Nasal Polyposis
por: Pelaia, Corrado, et al.
Publicado: (2023)

Asthma in the Precision Medicine Era: Biologics and Probiotics
por: Chiu, Chiao-Juno, et al.
Publicado: (2021)

Fractional Exhaled Nitric Oxide Nonsuppression Identifies Corticosteroid-Resistant Type 2 Signaling in Severe Asthma
por: Couillard, Simon, et al.
Publicado: (2021)

Biological therapy for severe asthma
por: Dragonieri, Silvano, et al.
Publicado: (2021)

Biologic Therapies in Pediatric Asthma
por: Perikleous, Evanthia P., et al.
Publicado: (2022)

Introduction to insect biology and diversity
por: Daly, Howell V.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_7jo3g4dd9lneva57j8ht3pgdo6